HLA-DRB1*09:01:02 antigen

Also Known As:

HLA-DRB1*09012; HLA-DRB1*09:01:02

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3
      - Histocompatibility Antigens Class II: 2170
        HLA-D Antigens: 238
        HLA-DR Antigens: 5477
        HLA-DR beta-Chains: 64
        HLA-DRB1 Chains: 2199
        HLA-DRB1*09:01:02 antigen: 3

Experts

1.	Chen, Wen: 1 article (11/2014)
2.	Hu, Bicheng: 1 article (11/2014)
3.	Qiu, Lixin: 1 article (11/2014)
4.	Tan, Yun: 1 article (11/2014)
5.	Tao, Ning: 1 article (11/2014)
6.	Wei, Yun: 1 article (11/2014)
7.	Wu, Xinxing: 1 article (11/2014)
8.	Wu, Xufeng: 1 article (11/2014)
9.	Zeng, Fanyu: 1 article (11/2014)
10.	Zhao, Min: 1 article (11/2014)

Related Diseases

1.	Papillomavirus Infections 01/01/2013 - "The risk associations of HPV infection were increased in women carrying the HLA-DRB109012 (OR = 1.924; 95% CI, 1.08 -3.427) and DRB3(52)0101 (OR = 7.527 95% CI, 0.909-62.347) alleles. "
2.	Hypersensitivity (Allergy) 03/01/2023 - "Our data suggest that the presence of HLA-B46:01:01/HLA-DRB109:01:02 is a potential marker of CBZ-induced hypersensitivity reactions in Vietnamese patients." 03/01/2023 - "We observed a higher prevalence of three alleles, HLA-B46:01:01, HLA-DQA103:02:01, and HLA-DRB109:01:02, in the CBZ hypersensitivity group compared to that in the CBZ tolerant group. " 03/01/2023 - "Next-generation sequencing-based HLA typing reveals the association of HLA-B46:01:01 and HLA-DRB1*09:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy."
3.	Epilepsy (Aura) 03/01/2023 - "Next-generation sequencing-based HLA typing reveals the association of HLA-B46:01:01 and HLA-DRB109:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy."
4.	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/01/2014 - "Conversely, the HLA-DRB109012 and HLA-DRB11201 alleles were found to be associated with a reduced cervical cancer risk. "

Related Drugs and Biologics

1.	HLA-DRB1 Chains (HLA DRB1)
2.	HLA-B Antigens (HLA-B)
3.	Carbamazepine (Tegretol)
4.	HLA-DQA1 antigen (HLA DQA1)